Efficacy and safety of tocilizumab in the treatment of Graves' orbitopathy: a systematic review and meta-analysis. [PDF]
Chen J, Chen Y, Huang H, Duan H.
europepmc +1 more source
Baseline selenium is associated with response to intravenous Methylprednisolone with selenium supplementation for thyroid eye disease in a selenium-sufficient area. [PDF]
Sung SM, Lee DC.
europepmc +1 more source
Thyroid Eye Disease, Glycemic Control, and the Role of a One-Stop Clinic Approach: A Retrospective Audit Study. [PDF]
Carter K +6 more
europepmc +1 more source
Approach to the patient: therapeutic mitigation of lacrimal manifestations in thyroid eye disease. [PDF]
Reinhardt C +5 more
europepmc +1 more source
The Management of Thyroid Eye Disease: From Current Practice to Future Perspectives. [PDF]
Dhaliwal NK, Razzaq L.
europepmc +1 more source
[The use of tocilizumab in severe glucocorticoid-resistant endocrine ophthalmopathy with optic neuropathy in clinical practice]. [PDF]
Sviridenko NY +9 more
europepmc +1 more source
Association Between Peripheral IL-2<sup>+</sup>Th1/CD4<sup>+</sup>Tregs Axis Imbalance and Dysthyroid Optic Neuropathy in Thyroid Eye Disease. [PDF]
Wang Z +9 more
europepmc +1 more source
Transcriptomic Profiling of Orbital Fat Tissue and Ocular Surface Wash in Active Thyroid Eye Disease Requiring Urgent Orbital Decompression. [PDF]
Petrácková A +5 more
europepmc +1 more source

